Posts Tagged ‘cancer’
Inova Schar Cancer Radiation Oncology Achieves Four-Year Accreditation for Radiation Oncology Services from ASTRO’s APEx – Accreditation Program for Excellence®
Falls Church, VA – Inova is proud to announce that all five radiation oncology departments within Inova Schar Cancer have been reaccredited by the American Society for Radiation Oncology (ASTRO) for APEx – Accreditation Program for Excellence®. APEx is an accreditation program developed by ASTRO that validates a radiation oncology facility’s excellence in delivering high…
Read MoreHealthy Summer Nutrition Tips
Lauren Fay, RD, CSO, CNSC, is a registered dietitian at the Inova Schar Cancer Institute and Life With Cancer. She is board-certified in oncology nutrition and nutrition support. Summer is well underway, and with the warmer temperatures (and the ability to spend time in larger groups of our vaccinated family and friends) many of us…
Read MoreEarly Study Finds MGC018 Active in Resistant Skin Cancer
Sekwon Jang, MD in medical oncology at Inova Schar Cancer Institute, presented the latest data on the multi-institutional Phase 1 clinical trial for MGC018 at the annual American Society of Clinical Oncology held June 4–8, 2021. What is MGC018? MGC018 is an investigational drug developed by MacroGenics that is being studied for the treatment of…
Read MoreColorectal Cancer Screening Should Begin at Age 45
Arthur Winer, MD, is a specialty care physician at Inova Schar Cancer Institute. Dr. Winer is board-certified in internal medicine, hematology and medical oncology. He is a practicing gastrointestinal medical oncologist and has clinical interests in colorectal, esophageal, gastrointestinal, liver and pancreatic cancers. For decades, experts advised people to begin colorectal cancer screening at age…
Read MoreSunscreen Facts: The Truth About Sun Protection & SPF
Patricia Lucey, MD, is a board-certified dermatologist at the Inova Melanoma and Skin Cancer Center. She has a special interest in the diagnosis and management of melanoma and other skin cancers. The summer sun is a welcome sight after a long winter. But sunshine has a dark side. Exposure to the sun’s ultraviolet (UV) rays…
Read MoreDiversity and Inclusion in Clinical Trials
Stephanie Van Bebber is Senior Director, Inova Schar Cancer Institute Clinical Trials Office at Inova. As we celebrate Clinical Trials Day this year, we recognize the extraordinary work that is done by research teams every day to ensure that future healthcare treatments and interventions are safe and effective. The date of May 20th honors James…
Read MoreIs Radiation Necessary After Breast Cancer Surgery?
Ductal carcinoma in situ (DCIS) is a cancer that forms in the cells that line the milk ducts, and it accounts for 20% of new breast cancer diagnoses. The most common treatment is breast-conserving surgery to remove the cancerous tissue. While only a small percentage of women experience an invasive cancer event following surgery, radiation…
Read MoreLife with Cancer: Anxiety in Grief
By Sarah Brooks, LPC, Oncology Clinical Therapist, Inova Life with Cancer “No one ever told me grief felt so like fear.” – C.S. Lewis When we are grieving, anxiety may emerge as part of our experience. Anxious thoughts and concurrent bodily responses can be adaptive in certain situations, but when they begin to pervade our…
Read MoreCancer News: A Look at The Future of Targeted Therapy
In the past, chemotherapy treatment was given to patients based on where in the body the cancer began, not taking in the factors of the molecular diversity of the individual patient’s cancer. Over the years, the development and advancement of the treatment for cancer has improved by applying molecular testing to determine individual patient tumors…
Read MoreInova’s Breast Cancer Team Takes a New Look at Hormone Therapy Treatment
A group of six Inova physicians have published a paper in the Annals of Surgical Oncology that could lead to re-thinking of treatment practices for individuals with breast cancer. The paper, published in November 2020, details the results of a systemic literature review that included over 6,000 patient cases. READ THE REPORT: Axillary Response in…
Read More